L Fernández Selected Research

policosanol

1/2006	Effects of policosanol on patients with ischemic stroke: a pilot open study.
1/2005	A comparison of the effects of D-003 and policosanol (5 and 10 mg/day) in patients with type II hypercholesterolemia: a randomized, double-blinded study.
1/2005	Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia.
1/2002	Comparison of the efficacy, safety and tolerability of original policosanol versus other mixtures of higher aliphatic primary alcohols in patients with type II hypercholesterolemia.
3/2001	Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk.
2/2001	A long-term study of policosanol in the treatment of intermittent claudication.
1/2001	Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.
6/2000	Effects of policosanol on postmenopausal women with type II hypercholesterolemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L Fernández Research Topics

Disease

5	Hypercholesterolemia 01/2005 - 06/2000
4	Neoplasms (Cancer) 02/2020 - 04/2001
3	Mastitis 06/2016 - 08/2008
2	Bone Resorption 01/2005 - 01/2001
2	Hypersensitivity (Allergy) 07/2004 - 12/2003
2	Lung Injury 07/2003 - 01/2001
1	Communicable Diseases (Infectious Diseases) 04/2021
1	Colonic Neoplasms (Colon Cancer) 02/2020
1	Colorectal Neoplasms (Colorectal Cancer) 02/2020
1	Nephrotic Syndrome (Syndrome, Nephrotic) 12/2019
1	Leukemia 01/2018
1	Ulcerative Colitis 11/2017
1	Neoplasm Metastasis (Metastasis) 11/2015
1	Osteosarcoma (Osteogenic Sarcoma) 11/2015
1	Tics (Tic) 11/2015
1	Bone Neoplasms (Bone Cancer) 11/2015
1	Hereditary Hemorrhagic Telangiectasia 08/2013
1	Urticaria (Hives) 01/2013
1	Gastroesophageal Reflux (GERD) 01/2010
1	Depressive Disorder (Melancholia) 05/2009
1	Thrombosis (Thrombus) 04/2009
1	Breast Neoplasms (Breast Cancer) 03/2009
1	Hemorrhage 01/2009
1	Disease Progression 09/2008
1	Infections 09/2008
1	Cross Infection (Nosocomial Infection) 09/2008
1	Critical Illness (Critically Ill) 09/2008
1	Septic Shock (Toxic Shock Syndrome) 04/2008
1	Sepsis (Septicemia) 04/2008
1	Intraabdominal Infections 04/2008
1	Stroke (Strokes) 01/2006
1	Ischemic Stroke 01/2006
1	DiGeorge Syndrome (Syndrome, DiGeorge) 10/2005
1	Headache (Headaches) 01/2005
1	Heartburn (Pyrosis) 01/2005
1	Nausea 01/2005
1	Coronary Disease (Coronary Heart Disease) 01/2005
1	Osteoporosis 01/2005
1	Metabolic Bone Diseases (Osteopenia) 01/2005
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 12/2004

Drug/Important Bio-Agent (IBA)

8	policosanolIBA 01/2006 - 06/2000
4	CholesterolIBA 01/2006 - 06/2000
3	Pharmaceutical PreparationsIBA 02/2020 - 06/2000
2	Biological ProductsIBA 02/2020 - 10/2019
2	SteroidsIBA 12/2019 - 11/2017
2	Biomarkers (Surrogate Marker)IBA 06/2016 - 01/2005
2	VitaminsIBA 01/2006 - 12/2004
2	AlcoholsIBA 01/2002 - 01/2001
2	SugarsIBA 01/2001 - 06/2000
1	Irinotecan (Camptosar)FDA LinkGeneric 02/2020
1	Interleukin-2 (IL2)IBA 01/2018
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2017
1	Proteins (Proteins, Gene)FDA Link 10/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2014
1	Omalizumab (Xolair)FDA Link 01/2013
1	Hormones (Hormone)IBA 05/2009
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 05/2009
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 04/2009
1	Citric Acid (Citrate)FDA LinkGeneric 03/2009
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2009
1	Liposomes (Liposome)IBA 03/2009
1	Docetaxel (Taxotere)FDA Link 03/2009
1	Trastuzumab (Herceptin)FDA Link 03/2009
1	Capsules (Microcapsules)IBA 01/2009
1	Meropenem (Merrem)FDA LinkGeneric 09/2008
1	Ertapenem (Invanz)FDA Link 04/2008
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2006
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2006
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2006
1	LDL CholesterolIBA 01/2005
1	Fish OilsIBA 01/2005
1	Mevalonic Acid (Mevalonate)IBA 01/2005
1	Bone Density Conservation AgentsIBA 01/2005
1	CreatinineIBA 01/2005
1	deoxypyridinolineIBA 01/2005
1	Alkaline PhosphataseIBA 01/2005
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2005
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2005
1	oxidized low density lipoproteinIBA 01/2005
1	MineralsIBA 12/2004
1	Dietary Fiber FDA Link 12/2004
1	Local AnestheticsIBA 07/2004
1	AmidesIBA 07/2004

Therapy/Procedure

6	Therapeutics 02/2020 - 02/2001
2	Lasers (Laser) 02/2020 - 10/2019
2	Drug Therapy (Chemotherapy) 01/2018 - 11/2015
2	Oral Administration 06/2016 - 08/2008
2	Liver Transplantation 04/2009 - 07/2003
2	Critical Care (Surgical Intensive Care) 09/2008 - 04/2008
2	Canes (Cane) 01/2001 - 06/2000
1	Phage Therapy 04/2021
1	Subcutaneous Injections 02/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018
1	Immunotherapy 11/2015
1	Epidural Analgesia 08/2013
1	Fundoplication 01/2010
1	Secondary Prevention 01/2006
1	Thrombolytic Therapy 01/2006
1	Ligation 10/2005
1	Ovariectomy (Oophorectomy) 01/2005